Anewbia 50 mg (Sitagliptin Hydrochloride Monohydrate)

Adult dose

This medication is administered once daily at a dosage of 100 mg for monotherapy or combination therapy, with a maximum daily dosage of 100 mg. For patients with renal impairment, dosage adjustment is required based on kidney function. - For mild and some moderate renal impairment (eGFR ≥ 45 mL/min/1.73 m² and < 60 mL/min/1.73 m²), dosage adjustment is not necessary. - For moderate renal impairment (eGFR ≥ 30 mL...

This medication may cause serious allergic reactions, so if symptoms such as skin rash or difficulty breathing occur, stop taking it immediately and consult a healthcare professional. While taking this medication, pancreatitis, which is inflammation of the pancreas, may occur, so if severe abdominal pain, vomiting, or nausea arise, you should seek medical attention immediately. This medication should not be used in patients with type 1 diabetes or diabetic ketoacidosis, and it should not be administered if there is an allergy to this medication or its components. Patients with reduced kidney function need dosage adjustments, so they should have regular kidney function tests and take this medication according to their healthcare provider's instructions. Clinical trials and post-marketing surveys have reported side effects such as hypoglycemia, headaches, upper respiratory infections, dyspepsia, diarrhea, etc., so if symptoms are severe or persistent, consult a healthcare professional. Especially when taken with other blood glucose-lowering agents such as insulin or sulfonylurea, the risk of hypoglycemia increases, so blood glucose levels should be monitored closely. If joint pain worsens or blisters occur during treatment with this medication, notify your physician immediately, and discontinuation of medication may be necessary. Pregnant or breastfeeding women should avoid using this medication, and safety and efficacy have not been established in children under 18 years of age. The elderly may have reduced kidney function, so kidney function should be assessed before use and periodic evaluations should be conducted during treatment. In case of overdose, seek medical care immediately for appropriate treatment; this medication can be partially removed by hemodialysis. No significant interactions with several other medications have been reported, but patients should inform their healthcare provider when taking specific medications.

Serious side effects

Hives, severe swelling (angioedema), chest tightness, difficulty breathing, cold sweat, pallor (severe allergic reaction), high fever with a severe rash, blisters, skin peeling, oral/ocular mucosal pain (severe skin abnormal reactions), difficulty breathing or breathlessness, asthma attack, respiratory issues accompanied by cough and fever (respiratory problems), yellowing of the skin or eyes (jaundice), extreme lethargy (liver dysfunction), sudden and severe...

Mild side effects

• Upper respiratory infection
• nasopharyngitis
• headache
• diarrhea
• nausea
• abdominal pain
• constipation
• vomiting
• muscle pain
• limb pain

This medication should be stored in a tightly closed container that is well-ventilated and kept at room temperature between 1 to 30 degrees Celsius. Storing it this way helps maintain the drug's effectiveness and prevents degradation.

Appearance

Yellow-orange, round, biconvex film-coated tablet

Package unit

28 tablets) 14 tablets/PTP (x2), 30 tablets) 10 tablets/PTP (x3)